Nucleome Therapeutics nominates first preclinical development candidate First-in-class monoclonal antibody agonist programme for inflammation resolution with broad applicability across major chronic ...

In a world where the immune system can be both hero and villain, three scientists have illuminated the path to taming its excesses. On October 6, 2025, ...

Data readouts planned for CLN-978 across all three autoimmune indications in 2026, including single dose and repeat dosing data Company to complete monotherapy expansion cohorts to determine recommend ...

Data readouts planned for CLN-978 across all three autoimmune indications in 2026, including single dose and repeat dosing dataCompany to ...

Xencor, Inc. , a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced corporate priorities and 2026 pipeline ...

Both upadacitinib (Rinvoq) and adalimumab (Humira) are proven effective in rheumatoid arthritis (RA) and psoriatic arthritis ...

Patients given a combination of Eli Lilly & Co.’s weight-loss shot Zepbound and arthritis drug Taltz saw a greater ...

SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...

Trial to resolve all claims in the Anaptys and Tesaro/GSK dispute is scheduled for July 14-17, 2026SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- ...

Tesaro and GSK contend that Anaptys’ Motion to Dismiss stays all discovery, a contention that Anaptys strongly opposes as the two companies work toward the scheduled July 14-17 trial date. The court ...

A new study has established a link between exposure to atmospheric pollution and modifications to the immune system that ...

Financial strain and food insecurity are drivers of accelerated biological heart aging, according to a recent study.